Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Qiagen buys Genaco for $22mm in cash plus earnouts

Executive Summary

Qiagen NV has acquired fellow molecular diagnostics company Genaco Biomedical Products for $22mm in cash and up to $18mm in earn-outs contingent upon receiving grants and funding. Qiagen also issued Genaco's founder 125k shares of restricted stock.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Payment Includes Stock
    • Intra-Biotech Deal
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register